0000950170-24-138009.txt : 20241218 0000950170-24-138009.hdr.sgml : 20241218 20241218175015 ACCESSION NUMBER: 0000950170-24-138009 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241218 DATE AS OF CHANGE: 20241218 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 241560449 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: AULIN SHERRY CENTRAL INDEX KEY: 0001862144 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A0 ZIP: V5G 48W 144 1 primary_doc.xml 144 0001862144 XXXXXXXX LIVE 0001582313 Xenon Pharmaceuticals Inc. 001-36687 3650 Gilmore Way Burnaby A1 V5G 4W8 (604)-484-3300 SHERRY AULIN Officer Common Shares Morgan Stanley Wealth Management Canada Inc.

Suite 1500, 600 - 3 Avenue SW Calgary Z4 T2P 0G5

18709 770909 76239602 12/18/2024 NASDAQ Common Shares 12/18/2024 Exercise of Options Issuer N 18709 12/18/2024 Net Exercise Y 12/18/2024 /s/ Sherry Aulin